Page 12 - Sartorius News Today

Sartorius will expand its capacities for production, innovation, and storage in France by investing 100 million euros between 2021 and 2025.

BERLIN (dpa-AFX) - Sartorius AG (SDMHF.PK), a German life science company, Thursday said it is investing around 270 million euros or around $300 million through the end of 2024 to expand its activities

Kevin Entzminger describes how Abwiz Bio is developing next-gen antibody therapeutics to help answer science questions

Download this white paper and discover how Sartorius analyse cosmetics to keep the users safe from harm

Kevin Entzminger describes how Abwiz Bio is developing next-gen antibody therapeutics to help answer science questions

BioNet and Sartorius’ BIA Separations are collaborating on production process development of mRNA vaccines: today announcing an optimized mRNA manufacturing process.

DJ Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: DECLARATION RELATIVE

Represents commitment to global efforts against COVID-19 with optimized mRNA production using proprietary chromatographic columns and process Manufacturing process successful in production

Sartorius Group products, product reviews and application articles on SelectScience.

News Summary: Collaboration to combine the Waters BioAccord LC-MS System as a bioprocess analyzer with the Sartorius Ambr bioreactor system gives bioprocess scientists both faster and direct access